Fair Value Calculator Fair Value Calculator
EN DE

MFSINTRCRP (MFSINTRCRP) Fair Value & Analysis

IN · Market cap ₹58.4M

M MFSINTRCRP MFSINTRCRP · BSE
Price₹13.50
Fair Value₹10.66
Upside-21.0%
Quality45/100
Watch MFSINTRCRP for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹7.04 – ₹13.33

Fair value as of: Jul 5, 2026

From 1 valuation models · updated today

Share price −21.9% over the past month.

Price vs Fair Value (12 months)

₹18.93 ₹11.20 Fair Value ₹10.66 Jul 2025 Jul 2026

12‑month range ₹11.20 – ₹18.93 · fair‑value band ₹7.04 – ₹13.33 · the ₹13.50 price screens above the ₹10.66 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

MFSINTRCRP (MFSINTRCRP) currently trades at ₹13.50, while our model-based Fair Value estimate is ₹10.66 — implying the stock looks roughly 21.0% overvalued today. We read business quality at 45/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, MFSINTRCRP generated revenue of ₹3.9M at a net margin of -6.0%. Revenue grew 242.3% year over year. It earns a return on equity of -0.8%. Net debt stands at ₹2.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹7.04 (bear case) to ₹13.33 (bull case); at ₹13.50, the current price sits above that range. The share trades about 29% below its 52-week high and 26% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹3.9M
Revenue growth (YoY) +242%
Net margin -6.0%
Return on equity -0.8%
Free cash flow −₹37.2M FY2026
Operating margin 74.9%
More key figures
EPS (TTM) ₹-0.0500
Net debt ₹2.1M FY2021

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

MFSINTRCRP reported revenue of ₹3.9M in FY2026 versus ₹107M in FY2022, a compound −56.3%/yr. Reported net income was −₹236K in FY2026.

Revenue −56.3%/yr
FY22 ₹107M
FY23 ₹22.0M
FY24 ₹0
FY25 ₹2.9M
FY26 ₹3.9M
Net income
FY22 ₹5.2M
FY23 ₹3.4M
FY24 −₹195K
FY25 −₹79.0K
FY26 −₹236K

Is MFSINTRCRP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "MFSINTRCRP Fair Value". https://www.fairvalue-calculator.com/stock/MFSINTRCRP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is MFSINTRCRP (MFSINTRCRP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹10.66 versus a price of ₹13.50 — about −21% (overvalued). Model-based estimate, not financial advice.
What is the fair value of MFSINTRCRP?
Our model-based fair value for MFSINTRCRP is ₹10.66 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹13.50.
What is the quality score of MFSINTRCRP?
MFSINTRCRP has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of MFSINTRCRP (MFSINTRCRP)?
MFSINTRCRP reported trailing-twelve-month revenue of about ₹3.9M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of MFSINTRCRP?
The net profit margin of MFSINTRCRP is about -6.0%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.